Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

ADPT Price Correlated With Financials For Adaptive Biotechnologies

Free historical financial statements for Adaptive Biotechnologies Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 9 quarters since 2020. Compare with ADPT stock chart to see long term trends.

ADPT Stock Compared to Quarterly

ADPT Income Statement

Revenue, Net:38620000
Revenue Per Share:0.2715
Cost of Goods & Services Sold:13192000
Selling, General & Admin Expense:26093000
Research & Development Expense:37839000
Total Operating Expenses:101687000
Operating Income:-63067000
Net Income:-62796000
Earnings Per Share, Basic:-0.44
Shares Outstanding, Basic Avg:142227952

ADPT Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:5109000
Net Cash from Operations:-64453000
Net Cash from Operations Per Share:-0.4532
Net Cash from Financing Activities:2749000
Property, Plant & Equipment Purchases:3077000
Net Cash from Investing Activities:37688000
Net Change in Cash & Equivalents:-24016000

ADPT Balance Sheet

Cash and Cash Equivalents:117187000
Accounts Receivable, Net:22518000
Inventories:21002000
Total Current Assets:419120000
Property, Plant & Equipment, Net:85994000
Total Assets:858193000
Accounts Payable:5959000
Total Short-Term Liabilities:115066000
Total Liabilities:304938000

Data imported from Adaptive Biotechnologies Corp SEC filings. Check original filings before making any investment decision.